-- 根據週二提交給印度證券交易所的文件顯示，製藥公司 Lupin（NSE：LUPIN，BOM：500257）已獲得美國食品藥物管理局 (FDA) 對其甘油苯丁酸酯口服液的批准。 甘油苯丁酸酯口服液與 Horizon Therapeutics U.S. Holdings 的參考製劑 Ravicti 口服液具有生物等效性，後者用於治療尿素循環障礙患者的慢性疾病。 根據 IQVIA 的估計，截至 2025 年 12 月，甘油苯丁酸酯口服液的年銷售額為 3.37 億美元。
Related Articles
Asia
CK Hutchison Cashes in on VodafoneThree Stake
CK Hutchison Holdings (HKG:0001) has agreed to dispose of its 49% stake in VodafoneThree to joint venture partner Vodafone, according to a Hong Kong bourse filing Tuesday.The firm is selling the stake for HK$45.5 billion to "monetize its investment at an attractive valuation."CK Hutchison expects to recognize a gain of around HK$4.7 billion from its stake sale in the mobile network operator, which services over 28 million customers in the U.K.
$HKG:0001
Asia
Alligator Energy Completes First Well Pattern at South Australia Field Trial
Alligator Energy (ASX:AGE) completed the first well pattern at its Samphire uranium project field recovery trial, marking a key step in demonstrating in-situ recovery performance under real field conditions, according to a Tuesday Australian bourse filing.The results met or exceeded the scoping study assumptions, confirming the strong technical viability of uranium recovery from the Samphire paleochannel system, per the filing.Key outcomes included strong permeability and fluid connectivity, around 70% uranium recovery within about 70 pore volumes, wellfield flow rates exceeding 5 liters per second, efficient reagent use within international benchmarks, and solution grades averaging 115 milligrams per liter of triuranium octoxide, the filing said.Groundwater chemistry and salinity had no negative impact, wellfield control remained stable, and ion exchange and elution performed successfully, confirming downstream processing viability.The company will initiate a second well pattern targeting lower-grade, less permeable zones to further assess recovery variability and refine future wellfield design, with results expected in the third quarter, the filing added.The company's shares rose 2% in recent Tuesday trade.
$ASX:AGE
International
Singapore's Retail Sales Jump 4.8% in March
Singapore's total retail sales rose 4.8% year on year in March, following the 8.3% growth in the preceding month, according to data released by the Department of Statistics Singapore on Tuesday.Excluding motor vehicles, retail sales climbed 3.3% on year in March.On a seasonally adjusted month-on-month basis, total retail sales were up 3.7% during the month, the data showed. Excluding motor vehicles, seasonally adjusted retail sales rose 3.3% in March.Estimated total retail sales came in at SG$4.7 billion in March, with online sales making up 15.7% of it, the data showed. Excluding motor vehicles, total retail sales stood at SG$3.8 billion.
$^STI